Pub. Date : 2021 Aug 13
PMID : 34441852
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Inotuzumab ozogamicin, the anti-CD22 antibody linked to calicheamicin led to complete remission rates of 60-80% in patients with relapsed/refractory B-ALL. | OZOGAMICIN | CD22 molecule | Homo sapiens |